Immunex Corporation

Type: Company

Name: Immunex Corporation

Nationality: United States

First reported May 08 2013 - Updated May 08 2013 - 2 reports

ZymoGenetics Incorporated

Frazier Healthcare raises $281M for latest venture fund

Seattle venture capital firm Frazier Healthcare has raised $281.8 million for its seventh fund, according to a SEC filing today. The company, which is targeting $300 million, has received the funds from 20 investors. Those funds include three percent ... [Published King5.com - May 08 2013]

Entities: Health Care, Achaogen Inc, ZymoGenetics Incorporated, Immunex Corporation

First reported Apr 17 2013 - Updated Apr 17 2013 - 1 reports

Gene therapy to restore muscle power to the heart nets UW spinoff $2.5 million

Damaged or weakened heart muscle that can’t pump enough blood to the rest of the body causes a host of problems that fall under the classification of heart failure. Researchers at the University of Washington have discovered a gene-based method they think ... [Published MedCity News - Apr 17 2013]

Entities: Gene Therapy, congestive heart failure, Cardio3 BioSciences SA, Celladon Corporation, Immunex Corporation

First reported Apr 16 2013 - Updated Apr 17 2013 - 1 reports

UW Spinout, Beat Bio, Gets $2.5M to Treat Heart Failure

Beat Biotherapeutics looked like it was in trouble after its co-founder and CEO died suddenly in June 2009. But the University of Washington spinout is definitely back in business, after recruiting a veteran CEO and raising another $2.5 million to advance ... [Published Xconomy - Apr 16 2013]

Entities: Stephen Quinn, congestive heart failure, Biotechnology

First reported Mar 27 2013 - Updated Mar 27 2013 - 1 reports

CfPIE Announces Advisory Board to Support Continued Life Sciences Training Alignment with Industry Regulations

Industry-active professionals converge to provide strategic guidance The , announced today that is has formed an advisory board to support the following mission: to help life science professionals stay compliant with worldwide regulatory requirements ... [Published PRWeb - Mar 27 2013]

Entities: Life Science, Advisory Board, Medical Devices

First reported Jan 15 2013 - Updated Jan 15 2013 - 1 reports

Amgen Inc

Amgen Whistleblower Fights To Unseal Documents

Despite a $762 million settlement between Amgen and the US Department of Justice for off-label marketing of various medicines ( back story ), the clash between the biotech and one of the whistleblowers is not over yet. A bitter dispute, in fact, continues ... [Published Pharmalot - Jan 15 2013]

Entities: Amgen Inc, Arbitration, Arbitrator, Whistle-Blower, Enbrel

First reported Dec 22 2012 - Updated Dec 22 2012 - 1 reports

Enbrel

ENBREL (Etanercept) Solution ENBREL (Etanercept) Kit [Immunex Corporation]

Updated Date: Dec 20, 2012 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Dec 22 2012]

Entities: Enbrel, Immunex Corporation

First reported Dec 20 2012 - Updated Dec 20 2012 - 1 reports

ENBREL (Etanercept) Solution ENBREL (Etanercept) Kit [Immunex Corporation]

Updated Date: Dec 20, 2012 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Dec 20 2012]

Entities: Enbrel, Immunex Corporation

Quotes

..." Rolando Hernandez M D a neurosurgeon with Neurological Wellness Center states; "This research elucidates the neurological mechanisms that enable improvements in walking ability, arm movement,speech, mood, and reductions in spasticity that we see in the patients we have treated with perispinally administered Enbrel brand etanercept. The treatment protocol utilized by Neurological Wellness Center was pioneered by Edward Tobinick M D in 2006 and described in . "TBI results in a self-perpetuating cycle of inflammation in the brain. This excess inflammation persists for years or even decades after the injury, This excess inflammation contributes to a portion of the many impairments our patients experience. Perispinally administered Enbrel reduces this inflammation in the brain, facilitating a recovery of function," stated Rolando Hernandez M D "Many individuals with TBI also suffer from severe depression. We encourage our clients to take the Oxford Happiness Questionnaire prior to treatment. This simple survey is available free and is automatically scored for you. Our clients are encouraged to take this survey 10 days and 30 days after the initiation of perispinal Enbrel treatment. The vast majority report improved happiness scores. I believe perispinally administered Enbrel may one day be used therapeutically as a severe depression treatment, " states Dr. Rolando Hernandez. "Perispinal Enbrel as a TBI treatment has many attributes. (1) The therapeutic window is wide. A person who's injury occurred a decade ago or even longer may still benefit. (2) The treatment is short term, involving just two to eight injections over a period of eight to forty days, yet the benefits are long lasting. (3) The dosage of Enbrel needed to achieve these results is quite low compared to the FDA recommendations for moderate plaque psoriasis. The FDA protocol for moderate plaque psoriasis calls for 24 injections totaling 1200 mg of Enbrel over a three month period, followed by weekly injections for life. Whereas a person with moderate to severe TBI would need a maximum of 8 injections totaling 200 mg of Enbrel in this period and would be unlikely to need even a single booster injection.injection. (4) The recovery, improvements can begin to occur in minutes and can build with subsequent injections over a four to eight week period," stated Dr. Hernandez."

Newly Published Medical Research Confirms the Efficacy of Perispinally... [Published PRWeb - May 15 2013]

...treatment decisions for gastroenterologists, patients and healthcare providers," said Anthony Yost, Chief Commercial Officer of Prometheus. "As the gastrointestinal healthcare community continues to further understand the long-term use of biologic agents in treating diseases like IBD, the need for comprehensive diagnostic tests like PROMETHEUS Anser ADA and PROMETHEUS Anser IFX becomes more critical, as does the value these novel assays offer in terms of time and expense saved when response to adalimumab or infliximab is lost."

Prometheus Launches New Adalimumab Drug And Antibody Levels Monitoring Test [Published Individual.com - Apr 30 2013]

More Content

sort by: Date \| Relevance
Promoting Dosing Accuracy with Prefilled Syringes [Published Pharmaceutical & Medical Packaging News - May 19 2013]
Newly Published Medical Research Confirms the E... [Published PRWeb - May 15 2013]
Frazier Healthcare raises $281M for latest vent... [Published King5.com - May 08 2013]
Frazier Healthcare nears final close for first ... [Published AltAssets.net - May 08 2013]
Novel Drug Treatment Quickly Reverses Traumatic... [Published Digital Journal - May 08 2013]
Insurers: Does Your Policy Contain a Broadly Wo... [Published JD Supra - Apr 30 2013]
Prometheus Launches New Adalimumab Drug And Ant... [Published Individual.com - Apr 30 2013]
Gene therapy to restore muscle power to the hea... [Published MedCity News - Apr 17 2013]
UW Spinout, Beat Bio, Gets $2.5M to Treat Heart... [Published Xconomy - Apr 16 2013]
Life Extension Foundation Seeks Volunteers with... [Published PRWeb - Apr 03 2013]
Congresswoman Michelle Bachmann Supports Barak ... [Published PRWeb - Apr 01 2013]
CfPIE Announces Advisory Board to Support Conti... [Published PRWeb - Mar 27 2013]
Blaze Bioscience Scores $8.5M [Published PE Hub News - Feb 22 2013]
Amgen Whistleblower Fights To Unseal Documents [Published Pharmalot - Jan 15 2013]
Neurological Wellness Center Posts 700% Sales I... [Published PRWeb - Jan 09 2013]
T2R taste receptors and genes encoding same [Published PharmCast - Jan 03 2013]
ENBREL (Etanercept) Solution ENBREL (Etanercept... [Published DailyMed Drug Label Updates for the last seven ... - Dec 22 2012]
ENBREL (Etanercept) Solution ENBREL (Etanercept... [Published DailyMed Drug Label Updates for the last seven ... - Dec 20 2012]
Enbrel Buyer’s Club Opens to Give Consumers a 4... [Published PRWeb - Dec 19 2012]
Concomitant treatment of rheumatoid arthritis w... [Published PharmCast - Nov 12 2012]
Cell lines expressing T1R2/T1R3 hetero-oligomer... [Published PharmCast - Aug 03 2012]

Blogs

sort by: Date \| Relevance
Amgen Whistleblower Fights To Unseal Documents [Published Pharmalot - Jan 15 2013] Despite a $762 million settlement between Amgen and the US Department of Justice for off-label marketing of various medicines ( back story ), the clash between the biotech and one of the whistleblowers is not over yet. A bitter dispute, in fact, continues ...
ENBREL (Etanercept) Solution ENBREL (Etanercept... [Published DailyMed Drug Label Updates for the last seven ... - Dec 22 2012] Updated Date: Dec 20, 2012 EST ...
ENBREL (Etanercept) Solution ENBREL (Etanercept... [Published DailyMed Drug Label Updates for the last seven ... - Dec 20 2012] Updated Date: Dec 20, 2012 EST ...